Credit Suisse Ag Amgen Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Amgen Inc stock. As of the latest transaction made, Credit Suisse Ag holds 1,096,086 shares of AMGN stock, worth $316 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

1,096,086

Previous 1,154,794 5.08%

Holding current value

$316 Million

Previous $333 Million 6.3%

% of portfolio

0.31%

Previous 0.33%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $15.8 Million - $19.1 Million	-58,708 Reduced 5.08%	1,096,086 $312 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $1.59 Million - $1.8 Million	6,224 Added 0.54%	1,154,794 $333 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $34.7 Million - $43.1 Million	-158,594 Reduced 12.13%	1,148,570 $309 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $24 Million - $28.3 Million	-111,883 Reduced 7.88%	1,307,164 $290 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $33.5 Million - $40.8 Million	148,314 Added 11.67%	1,419,047 $343 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $1.49 Million - $1.9 Million	-6,518 Reduced 0.51%	1,270,733 $334 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $19.6 Million - $22.1 Million	-87,168 Reduced 6.39%	1,277,251 $288 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $44.4 Million - $49.4 Million	-192,328 Reduced 12.35%	1,364,419 $332 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $26.4 Million - $29.2 Million	120,407 Added 8.38%	1,556,747 $376 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $45.7 Million - $52.3 Million	229,849 Added 19.05%	1,436,340 $323 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $44.8 Million - $52.5 Million	-210,934 Reduced 14.88%	1,206,491 $257 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $24.5 Million - $27.1 Million	104,691 Added 7.98%	1,417,425 $345 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $55.5 Million - $64.6 Million	-249,880 Reduced 15.99%	1,312,734 $327 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $36.1 Million - $43 Million	166,762 Added 11.95%	1,562,614 $359 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $45.8 Million - $50.9 Million	-195,003 Reduced 12.26%	1,395,852 $355 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $59.8 Million - $73.4 Million	302,210 Added 23.45%	1,590,855 $375 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $9.75 Million - $12.9 Million	-53,507 Reduced 3.99%	1,288,645 $261 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $27.2 Million - $35 Million	143,881 Added 12.01%	1,342,152 $324 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $22.5 Million - $27 Million	-129,411 Reduced 9.75%	1,198,271 $232 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $2.69 Million - $3.15 Million	-16,139 Reduced 1.2%	1,327,682 $245 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $2.52 Million - $2.84 Million	13,954 Added 1.05%	1,343,821 $255 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $651,516 - $760,529	3,652 Added 0.28%	1,329,867 $259 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $9.18 Million - $10.3 Million	49,518 Added 3.88%	1,326,215 $275 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $81.8 Million - $91.9 Million	-492,481 Reduced 27.84%	1,276,697 $236 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $49 Million - $57.3 Million	289,173 Added 19.54%	1,769,178 $302 Million
Q4 2017 Mar 14, 2018	BUY	$168.79 - $188.59 $10.4 Million - $11.7 Million	61,860 Added 4.36%	1,480,005 $257 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $23.3 Million - $26 Million	-138,118 Reduced 8.87%	1,418,145 $247 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $21.1 Million - $24.1 Million	-126,110 Reduced 7.5%	1,556,263 $290 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,682,373	1,682,373 $290 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account